Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502

BACKGROUND: Previous studies have suggested that patients with esophageal squamous cell carcinoma (ESCC) are still at a high risk of developing second primary malignancies (SPMs) after definitive therapies. We evaluated the development of SPMs and explored its risk factors in patients with clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitani, Seiichiro, Kato, Ken, Daiko, Hiroyuki, Ito, Yoshinori, Nozaki, Isao, Kojima, Takashi, Yano, Masahiko, Nakagawa, Satoru, Ueno, Masaki, Watanabe, Masaya, Tsunoda, Shigeru, Abe, Tetsuya, Kadowaki, Shigenori, Kadota, Tomohiro, Sasaki, Keita, Machida, Ryunosuke, Kitagawa, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article—Alimentary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232445/
https://www.ncbi.nlm.nih.gov/pubmed/35546373
http://dx.doi.org/10.1007/s00535-022-01870-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232445/
https://www.ncbi.nlm.nih.gov/pubmed/35546373
http://dx.doi.org/10.1007/s00535-022-01870-y

Ejemplares similares